Patient demand is equal “and now arguably greater” than at the first wave’s peak, the service says.
Related Articles
-
Here’s why I am coining the term “embryo tech”
I’m not sure how much money has been plowed into embryonic stem cells so far, but it’s definitely in...
-
The Download: the cancer vaccine renaissance, and working towards a decarbonized future
Last week, Moderna and Merck launched a large clinical trial in the UK of a promising new cancer therapy:...
-
What babies can teach AI
But what if an AI could learn like a baby? AI models are trained on vast data sets consisting...
-
Composable enterprise spurs innovation
Overall, 74% of companies accelerated plans to move to the cloud by more than a year, jettisoning legacy technologies...
Recent Comments